Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 8mg
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Impurities/Degradation Specifications
- Products
-
- Cardura XL (doxazosin) extended release tablets 8mg
- Company
- Viatris Inc
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- 3,694 bottles
- About this recall
- Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-10